2022 annual financial data

HCW Biologics 2022 Financial results

Direct answer

Revenue was 6,722,090 USD.

Operating income was -15,078,778 USD and net income was -14,900,703 USD.
Operating cash flow was -10,386,110 USD.

Get free HCW Biologics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
6,722,090 USD
Operating income
-15,078,778 USD
Net income
-14,900,703 USD
Operating cash flow
-10,386,110 USD